Stamford, CT -- (SBWIRE) -- 10/25/2013 -- Jet Life Penny Stocks provides investors with the some of the most Awesome Penny Stock alerts on a regular basis. We will send you alerts through our Penny Stock Newsletter and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Here are some trending Stocks in focus: Brink's Company(NYSE:BCO), Repros Therapeutics Inc(NASDAQ:RPRX), Dyax Corp.(NASDAQ:DYAX), Rentech, Inc.(NASDAQ:RTK)
Brink's Company(NYSE:BCO) stock is at $30.62, up +4.43 percent from its previous close of $29.32. The stock opened the session at $30.00 and touched its highest price point at $32.67. Brink's Company stock’s lowest price point for the session stood at $29.90. Stocks graphical chart shows a bullish trend during its last one month’s trading session. It remained positive 13.28% during the previous three months trade. Its total trading volume is 1.18 million shares for the day, in comparison to its average trading volume of 175,062.00 shares. The Brinks Company, together with its subsidiaries, provides secure transportation, cash management services, and other security-related services to banks and financial institutions, retailers, government agencies, mints, jewelers, and other commercial operations worldwide.
For How Long BCO’s Gloss will Attract Investors ? Find out via this report
Repros Therapeutics Inc(NASDAQ:RPRX) stock is at $17.87, up +4.38 percent from its previous close of $17.12. Its today’s volume is 1.44 million shares, in comparison to its average trading volume of 1.03 million shares. The stock opened the session at $17.05 and touched its highest price point at $18.48. Repros Therapeutics ’s lowest price point for the session stood at $17.00 and its 52 week price range stood at $8.42 - $29.79. The company has a total of 23.00 million outstanding shares and its total market capitalization is $411.10 million. Its beta value stands at -0.04 times and earnings per share was $-1.55. Repros Therapeutics Inc., a development stage biopharmaceutical company, engages in the development of new drugs to treat hormonal and reproductive system disorders
For How Long RPRX will fight for Profitability? Read This Trend Analysis report
Dyax Corp.(NASDAQ:DYAX) opened the session at $6.53 and remained in the $6.45 to $6.82 price range during the session. The stock is +4.29 percent higher at $6.80. Volume closed the day at 1.10 million shares, its average volume being 1.25 million shares. The company has a total of 109.26 million outstanding shares and its total market capitalization is $742.97 million. Its beta value stands at 1.69 times and earnings per share was $-0.30. DYAX was a gainer in the 5 days activity and jumped about 4.53%. The one month performance of the stock was positive and it scored more than 12.21%. Dyax Corp., a biopharmaceutical company, engages in the identification, development, and commercialization of treatments for plasma kallikrein-mediated (PKM) angioedemas.
Will DYAX Continue To Move Higher? Find Out Here
Rentech, Inc.(NASDAQ:RTK) percentage change mounted +4.31%, to close at $2.20 with the total traded volume of 1.39 million shares, less than average volume of 1.67 million. Company’s year to date performance remained declining as it almost -13.73% . If we look at the last 6 months of trade, that is in the bearish zone with a drop of -0.9%. The 52-week price range of the stock remained $1.82 - $3.18, while during last trade its minimum price was $2.09 and it gained its highest price of $2.20. Rentech, Inc., through its subsidiaries, engages in the manufacture and sale of natural-gas based nitrogen fertilizer products in the United States and Brazil.
Why Should Investors Buy RTK After The Recent Gain? Just Go Here and Find Out
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Jet Life Penny Stocks also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)